Spectrum Pharmaceuticals, Inc. (SPPI)

4.72
0.16 3.50
NASDAQ
Prev Close 4.56
Open 4.61
Day Low/High 4.57 / 4.79
52 Wk Low/High 1.74 / 10.57
Volume 1.08M
Exchange NASDAQ
Shares Outstanding 145.92B
Market Cap 665.41M
P/E Ratio N/A
Div & Yield N.A. (N.A)
Pacific Biosciences Shares Down After Third-Quarter Results -- Biotech Movers

Pacific Biosciences Shares Down After Third-Quarter Results -- Biotech Movers

The Menlo Park, Calif.-based firm had a third-quarter net loss of $22 million, compared with $17.5 million in the year-ago period. Product, service and other revenue rose 9% year-over-year to $23.5 million.

Spectrum Shares Surge on Data for Lung Cancer Drug -- Biotech Movers

Spectrum Shares Surge on Data for Lung Cancer Drug -- Biotech Movers

The Henderson, Nev.-based company said interim data from a Phase 2 study showed an objective response rate of 73%.

Making a Plan for Spectrum

Making a Plan for Spectrum

You can add to long with close above $8.57.

5 Dumbest Things on Wall Street

5 Dumbest Things on Wall Street

Bloomberg's Boner, Wal-Mart's World, Depressing Dell and Phony Sony are among Gregg Greenberg's 5 Dumbest Things on Wall Street this week.

The 5 Dumbest Things on Wall Street: March 15

The 5 Dumbest Things on Wall Street: March 15

Soda bans, electronics retailer upgrades and a stock that will not be music to anyone's ears. TheStreet's Gregg Greenberg has this week's 5 Dumbest Things on Wall Street.

The 5 Dumbest Things on Wall Street: December 14

The 5 Dumbest Things on Wall Street: December 14

Here is this week's roundup of the dumbest actions on Wall Street.

Stocks Under $5: Discount Drug Name

Stocks Under $5: Discount Drug Name

Portfolio manager David Peltier analyzes a volatile, low-dollar drug stock.

The Next Big Thing in Biotech

The Next Big Thing in Biotech

Adam Feuerstein, senior columnist for TheStreet, says biotech earnings are the next big thing to watch in biotech.

Hefty Action in a Pair of Biotechs

Hefty Action in a Pair of Biotechs

I've got my eye on these, though I wouldn't act until the market decides on a direction.

A Gap Up and Fade

A Gap Up and Fade

The action is strong, but the market isn't gaining additional traction.

Trades Can Still Work When Things Stink

Trades Can Still Work When Things Stink

There isn't necessarily any correlation between the way stocks trade and the feeling about the economy.

Biotech Has Momentum

Biotech Has Momentum

Takeover news has the sector buzzing this morning.